EP3484524
Efnasambönd og aðferðir til stillingar á SMN2
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.7.2017EP published:
9.11.2022EP application number:
17828625.8
EP translation filed:
9.1.2023Grant published:
15.2.2023EPO information:
European Patent Register
Max expiry date:
16.7.2037Expiry date:
16.7.2026Next due date:
31.7.2026
Title in English:
COMPOUNDS AND METHODS FOR MODULATION OF SMN2Language of the patent:
English
Timeline
Today
17.7.2017EP application
9.11.2022EP Publication
9.1.2023Translation submitted
15.2.2023Registration published
16.7.2026Expires
Owner
Name:
Ionis Pharmaceuticals, Inc.Address:
2855 Gazelle Court, Carlsbad, CA 92010, US
Inventor
Name:
RIGO, FrankAddress:
Carlsbad, CA 92010, US
Name:
PRAKASH, Thazha, P.Address:
Carlsbad, CA 92010, US
Name:
SETH, Punit, P.Address:
Carlsbad, CA 92010, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662363195 PDate:
15.7.2016Country:
US
Classification
Categories:
C07H 21/02, A61K 48/00, A61P 21/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 22.6.2023
Expires: 16.7.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 19.6.2024
Expires: 16.7.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.7.2025
Expires: 16.7.2026
Payer: Árnason Faktor ehf.